Does inorganic arsenic detoxification rely on one-carbon methylation and increase methylation demand?

Exposure to inorganic arsenic poses significant toxicological challenges, particularly for older adults where metabolic efficiency may already be compromised. Arsenic clearance relies directly on the body's primary biochemical methylation pathway.

Biochemical mechanisms of detoxification

• The enzyme arsenic methyltransferase (AS3MT) drives detoxification by sequentially methylating toxic trivalent inorganic arsenite (As(III)) into monomethylated (MMA) and dimethylated (DMA) species for renal excretion.
• This process depends entirely on S-adenosylmethionine (SAM) derived from the folate and methionine cycles of one-carbon metabolism. Every methylation step converts SAM to S-adenosylhomocysteine (SAH), making detoxification highly sensitive to the cellular SAM/SAH ratio.
• Insufficient methylation traps arsenic as monomethylarsonous acid (MMA(III)), a highly cytotoxic and genotoxic intermediate that increases systemic tissue retention.

Elevated nutritional and metabolic demand

• Arsenic detoxification directly competes with other essential cellular processes, such as DNA methylation, for the finite systemic pool of SAM.
• Chronic exposure increases nutritional requirements for critical methyl donors, specifically folate and vitamin B12, to sustain both detoxification and basic epigenetic maintenance.
• Randomized controlled trials show that supplementing with 400–800 µg/day of folic acid, alone or with vitamin B12, restores SAM levels, shifts arsenic speciation toward non-toxic DMA, and significantly lowers total blood arsenic levels.

Bottom line

• Inorganic arsenic detoxification depends heavily on SAM-driven methylation; chronic exposure increases demand on the one-carbon metabolism pool, making adequate folate and vitamin B12 intake critical to facilitate renal excretion and prevent the accumulation of toxic intermediates.